Member Info for potnak

Bluenose, I'm not unsure of the route we seem to be taking as I believe it is an insurance policy. What does puzzle me though, is if 1801 TYK2 is as good as we think, why no licencing deal yet. I suspect it is because SAR are a micro-cap company and as such don't have the negotiating power. Raising £30 million from an institution would give us the power to walk away from a bad deal. Unfortunately, we might have to give away 10% of the company to get it. I honestly think the sole reason for the consolidation is to get some major investment from an institution. If done right, we all win anyway so just get on with it.

As far as I know, We would need a CTA for each trial. However, once we have one approved, the others should be easy, unless the design of the trial changes significantly.

Luton - I never make New Year resolutions but this year, I'm aiming to take out the emotion from my investing. Life is too short to be dreaming. The LTH had an amazing 2021 with SAR, far better than I originally wanted when I first invested all those years ago. So I asked myself why didn't I sell. At 2021 highs, I could have walked away with approx £230k profit from and £18 investment. I don't regret that decision for a second because I believe I will get more than that when I sell but by acknowledging why invested in the first place and taking the emotion out of the decisions, I can see a clearer picture. IMO the consolidation means there is no buyout on or anywhere near the table and the engagement of Peel Hunt means, the board are aiming to raise more funds. Again, IMO both these things will happen before we get any substantial news flow. I think the last HNWI subscription at 5p was an attempt to underpin the SP but the MM's have again taken the lack of clarity with everything else as a trigger to walk the SP down.

Peel cant control the SP though. PH market makers and PH the broker are two completely different things and it would be illegal for them to share information. Other than SRA737 and possibly 1801 Covid, we pretty much know that there isn't going to be any major news this quarter. I said possibly 1801 Covid because, whether it is fast-tracked or not, we will still need the tox report to file a CTA. We will get the tox data readout in Q1 but in reality, this is just a ticking a box for the 1801 CTA which could be 6 months away. The market knows of the consolidation and the MM's will take advantage of that until the consolidation is done. It will be much harder to drive the SP down on a few million shares sold when a few million shares sold actually means a few million pounds. Do it now, before the MM's can walk it down, take the inevitable hit the consolidation will bring then manage the SP back up. There will be some casualties but most LTH and some of newer holders will have no intention of selling at 3p. It's just noise until news flow starts up again.

Firstly, Happy New Year to all.

I'm hoping that the board have for plans to initiate the consolidation sooner rather than later, this week even? Nothing will happen with the news flow until the consolidation is done and the board will know this for a fact so we are in no man's land until we have some certainty with the market cap. I've read a lot of the consolidation posts here in the last few weeks and I will vote for a consolidation whatever the ratio is, with a 30\1 being my personal preference. So to Tim, Parker et al. Just do it now and please manage the SP and our expectations afterwards. 2022 H1 is going to be a good one IMO.

Good Post sog. I'm in agreement with you. PH have been brought in to raise funds that will effectively make Sareum a proper bio tech company or JV. On the fundraising, you only have to look at the news section on the PH website to see that's what they do. I was also thinking £25-30 million too. I still think the sar compounds are up for sale, just not cheap. Raising funds is an insurance policy.

Yes, all approximate at the moment. The thing is. Share consolidations are smoke and mirrors. The SP=MC/shares in issue. I happen think that sareum will have a Market cap of 2 billion by this time next year.

28p now would require a 900 million NC. Need to work that out against 350 million shares.

Back of fag packet calculations. In a 10/1 scenario £2.55 would be the new 28p ??

If they did a 10/1 consolidation right now. Each share would be worth 53p. A 20/1 would give you an sp of £1.06. Its easy to workout.

If the market cap = a £5 sp with 3.5 billion shares the sane market cap will = £50 with 350 million shares. I agree though. Some of the more outlandish predictions seem ludicrous in the context of a 10/1 consolidation. Let's use market cap for future predictions. I'm still going for 2 billion.

I always cringe a bit when I see posts like this. My first though is, Should I invest in a company that's needs the help of its investors to get the message out. If I really thought SAR needed our help, I'd sell in an instant.

However, They don't need our help, all is in hand. Just log off and come back on the 4th Jan. Lots happening next year.

To add to Lutons post. Sareum have built a company worth hundreds of millions with less than 20 million raised from its investors. Its a success story how ever you look at it.

To add to Lutons post. Sareum have built a company worth hundreds of millions with less than 20 million raised from its investors. Its a success story how ever you look at it.

I know I'm stating the obvious or at least, I hope I am. The Share price = Market cap / shares in issue. That's it! At the moment of the consolidation, each and every shareholder will have shares that will be worth exactly the same as they were before the consolidation. That's not to say the SP won't fall afterwards, on AIM, it usally does in my experience. The other negative is that some companies use the lower number of shares in issue as a raising opportunity. You only have to look a VAL's history for that. That said, there are some positives. The biggest one is we look more professional to the institutions. Penny shares are erratic and have the SP at say 55p will to some extent protect us from the Mm's dropping the SP on a few millions shared sold. If we do have any more HNWi waiting to invest better to do it before the consolidation just do everything is neat and know as we go into 2022. Only problem for us holders is we'll have to change the name of the 10p, 28p or 1 pound party. Hopefully, the invites have already been printed. :-)

I wonder what the new 28p will be? I reckon about 3 quid.

I was too busy to join the AGM today. On the consolidation, I'm not a fan on AIM but can see that we are at that point where less shares in circulation will result in more confidence for big investors. Its all smoke and mirrors though. The consolidation also signals the direction we are heading. No buyout on the horizon, at least until P2 trials. I'm ok with that if value is added on the P1 deals. On tox results. I did say I was on the fence. I thought they might release the news without a fanfare. As Thoth said, there is something going on. My guess is a consolidation while the sp is between 5 and 6p the PH will jump in with a big investor via a placing. All this will happen before Sierra news to derisk the new investors cash. Hopefully, if this us the case, the cash raised will be enough to put 1801 and 1802 through P1. Then we can seek a licence deal safe in the knowledge we can go it alone if needed. All in all, a bit more can kicking but I'm happy to keep my 2.5 million shares in my back pocket.

Same sentiments. Well said. It's exhausting. I'm here for Sareum and nothing else.

Same sentiments. Well said. It's exhausting. I'm here for Sareum and nothing else.

Well PH mates must not have much cash. Look at the volume. Tiny amount of shares traded. It just standard for AIM. Parkers retweet this morning was the biggest clue yet that preclinical has gone well. He said about to finish preclinical! I'd say that means in the next few weeks, days even. I would make sense to announce this before the AGM and Investor Meet event.